- Trials with a EudraCT protocol (29)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
29 result(s) found for: Contact lenses.
Displaying page 1 of 2.
EudraCT Number: 2011-003692-12 | Sponsor Protocol Number: AZ02 | Start Date*: 2012-05-09 |
Sponsor Name:AZAD Pharma AG | ||
Full Title: A phase III , multicentre, randomised, investigator-masked, cross-over, comparative efficacy study of a generic Brinzolamide 10 mg/ml ophthalmic suspension (Azad Pharma AG) and Brinzolamide 10 mg/m... | ||
Medical condition: Patients suffering from open angle glaucoma and ocular hypertension with an elevated IOP, higher than 22mmHg and and lower or equal than 35 mmHg | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: PL (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-001460-11 | Sponsor Protocol Number: 15/0599 | Start Date*: 2016-06-30 | |||||||||||
Sponsor Name:UCL CCTU | |||||||||||||
Full Title: Corneal cross-linking versus standard care in children with keratoconus, a randomised, multicentre, observer-masked trial of efficacy and safety | |||||||||||||
Medical condition: Patients with progressive keratoconus disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002744-25 | Sponsor Protocol Number: RK100.1 | Start Date*: 2006-06-29 |
Sponsor Name:Roskamp Institute | ||
Full Title: An open label evaluation of the safety and efficacy of nilvadipine in mild to moderate Alzheimer's Disease | ||
Medical condition: Alzheimer's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-003355-39 | Sponsor Protocol Number: E2020-E044-318 | Start Date*: 2004-09-14 |
Sponsor Name:Eisai Limited | ||
Full Title: A 52-week, multicentre, open label extension study of the safety, tolerability and efficacy of donepezil (Aricept) in Parkinson's disease patients with dementia. | ||
Medical condition: Dementia associated with Parkinson's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-002760-34 | Sponsor Protocol Number: C-08-10 | Start Date*: 2008-10-02 | ||||||||||||||||
Sponsor Name:Alcon Research, Ltd. | ||||||||||||||||||
Full Title: A Multi-Center, Double-Masked Study of the Safety and Efficacy of Travoprost APS Compared to TRAVATAN® in Patients with Open-Angle Glaucoma or Ocular Hypertension | ||||||||||||||||||
Medical condition: Open-Angle Glaucoma or Ocular Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-002524-12 | Sponsor Protocol Number: BNZ-20-01-2022 | Start Date*: 2023-04-13 |
Sponsor Name:AZAD Pharma AG | ||
Full Title: A prospective, phase III, multicenter, randomized, investigator-blinded, two-arm, parallel groups, non-inferiority clinical trial for the comparison of efficacy and safety of a preservative-free Br... | ||
Medical condition: GLAUCOMA , OCCULAR HYPERTENSION | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BG (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001324-34 | Sponsor Protocol Number: C-12-008 | Start Date*: 2013-03-07 |
Sponsor Name:Alcon Research Ltd | ||
Full Title: A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients | ||
Medical condition: Pediatric glaucoma;elevated intraocular pressure | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Completed) GB (Completed) PL (Completed) DE (Completed) PT (Completed) NL (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-001727-39 | Sponsor Protocol Number: POP03 | Start Date*: 2018-10-16 | ||||||||||||||||
Sponsor Name:Polpharma S.A. | ||||||||||||||||||
Full Title: A PHASE III, MULTICENTRE, RANDOMISED, INVESTIGATOR-MASKED, CROSSOVER, COMPARATIVE, NON-INFERIORITY TRIAL EVALUATING THE EFFICACY AND TOLERABILITY OF GENERIC LATANOPROST 0.05 MG/ML EYE DROPS SOLUTIO... | ||||||||||||||||||
Medical condition: Ocular hypertension and open angle glaucoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-001640-22 | Sponsor Protocol Number: C-12-009 | Start Date*: 2013-03-25 |
Sponsor Name:Alcon Research Ltd | ||
Full Title: An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients | ||
Medical condition: Paediatric glaucoma | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) BE (Completed) ES (Completed) FR (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2007-001688-31 | Sponsor Protocol Number: 604296B | Start Date*: 2007-06-04 | |||||||||||
Sponsor Name:Larime company of the Mediscis group | |||||||||||||
Full Title: Monitoring des états cognitifs chez des sujets volontaires sains, sur 2 périodes, l'une avant et après administration d'une dose unique de Zolpidem, l'autre sans administration de traitement | |||||||||||||
Medical condition: It's a phase II study performed on healthy volonteers. Zolpidem (DCI) will be administered to the volunteers in order to inducing a drowsiness and a hypoattentiveness. Zolpidem is indicated in the ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003326-13 | Sponsor Protocol Number: BTI-011-EC/15/QUER | Start Date*: 2016-01-05 |
Sponsor Name:BTI Biotechnology Institute I mas D | ||
Full Title: Randomized, parallel groups, multicenter and blind to evaluators clinical trial, to evaluate the efficacy and safety of PRGF-Endoret eye drops, in patients with stage 2 and 3 neurotrophic keratitis. | ||
Medical condition: Neurotrophic Keratitis (NK) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-018441-61 | Sponsor Protocol Number: 637 | Start Date*: 2010-12-02 |
Sponsor Name:Dr. Gerhard Mann chem.-pharm. Fabrik GmbH/ Bausch & Lomb Incorporated | ||
Full Title: A Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Multicenter, Exploratory Study Assessing Safety and Efficacy of BOL-303242-X | ||
Medical condition: Dry eyes | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-003356-38 | Sponsor Protocol Number: C-05-03 | Start Date*: 2006-11-07 |
Sponsor Name:Alcon Research Limited | ||
Full Title: A Study of the Safety and Efficacy of Anecortave Acetate for Treatment of Steroid Induced IOP Elevation | ||
Medical condition: Elevated intraocular pressure (IOP) following intravitreal injection with a corticosteroid (steroid induced IOP elavation). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) NL (Completed) HU (Completed) GB (Completed) ES (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000286-36 | Sponsor Protocol Number: LEVODESA_04-2017 | Start Date*: 2018-08-28 | |||||||||||
Sponsor Name:NTC s.r.l. | |||||||||||||
Full Title: An international, multicenter, randomized, blinded-assessor, parallel-group clinical study comparing eye drops of combined LEvofloxAcin + DExamethasone foR 7 days followed by dexamethasone alone fo... | |||||||||||||
Medical condition: Prevention and treatment of inflammation and prevention of infection associated with cataract surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004775-13 | Sponsor Protocol Number: SYD-101-001 | Start Date*: 2019-08-02 | |||||||||||
Sponsor Name:Sydnexis, Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study to Assess the Safety and Efficacy of SYD-101 Ophthalmic Solution for the Treatment of Myopia in Children | |||||||||||||
Medical condition: Myopia | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Trial now transitioned) AT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004768-22 | Sponsor Protocol Number: C-05-30 | Start Date*: 2006-06-12 | |||||||||||
Sponsor Name:ALCON ITALIA | |||||||||||||
Full Title: Clinical study of the mast-cell stabilizing effects of the Olopatadine using the Conjunctival Allergen Challeenge model | |||||||||||||
Medical condition: subjects with a clinical history of seasonal allergic conjunctivitis, but asymptomatic and free of any topical or systemic medication at baseline | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002595-34 | Sponsor Protocol Number: MRZ 92579-0707/1 | Start Date*: 2008-03-11 | ||||||||||||||||
Sponsor Name:Merz Pharmaceuticals GmbH | ||||||||||||||||||
Full Title: Efficacy and safety of neramexane mesylate in congenital idiopathic nystagmus and acquired nystagmus: a randomized, double-blind, placebo-controlled, single center, proof of concept study using a t... | ||||||||||||||||||
Medical condition: Congenital idiopathic nystagmus and acquired nystagmus | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-004766-16 | Sponsor Protocol Number: C-05-10 | Start Date*: 2006-02-17 |
Sponsor Name:Alcon Research, Ltd. | ||
Full Title: Comparison of Safety and Efficacy of Brinzolamide/Timolol Fixed Combination vs COSOPT in Patients with Open-Angle Glaucoma or Ocular Hypertension | ||
Medical condition: Open Angle Glaucoma or Ocular Hypertension ICD: H40.1/H40.0 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) BE (Completed) GB (Completed) LT (Completed) LV (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-002987-57 | Sponsor Protocol Number: AL002-LTE | Start Date*: 2023-03-09 | |||||||||||
Sponsor Name:Alector Inc. | |||||||||||||
Full Title: A Multicenter, Long-Term Extension Study to Evaluate the Safety, Tolerability, and Efficacy of AL002 in Participants with Alzheimer’s Disease | |||||||||||||
Medical condition: Early Alzheimer's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) NL (Trial now transitioned) DE (Trial now transitioned) ES (Ongoing) PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005575-12 | Sponsor Protocol Number: BYON5667.002 | Start Date*: 2021-06-30 | ||||||||||||||||
Sponsor Name:Byondis B.V. | ||||||||||||||||||
Full Title: A multicenter, randomized, double-blind, placebo-controlled trial with a single arm run-in period to evaluate the safety and efficacy of sodium thiosulfate (BYON5667) eye drops to reduce ocular tox... | ||||||||||||||||||
Medical condition: Single arm run-in period: Patients with solid tumours (excluding gastric tumours and adenocarcinomas of the gastroesophageal junction) Randomized part of the study: patients with locally advanced ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
